Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
olfactory receptor family 10 subfamily Z member 1 | 0.11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2009 | ||||||||||
|
testis expressed 33 | 1.2E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2009 | 2009 | ||||||||||
|
synthesis of cytochrome C oxidase 2 | 0.479 | 0.846 | 7.5E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2009 | 2009 | ||||||||
|
solute carrier family 17 member 3 | 0.769 | 0.385 | 4.9E-22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2009 | 2009 | ||||||||
|
prickle planar cell polarity protein 4 | 0.839 | 0.154 | 4.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2009 | 2009 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2019 | ||||||||
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene | 0.805 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2019 | |||||||||
|
mediator complex subunit 20 | 0.861 | 0.077 | 0.30 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2009 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2019 | ||||||||
|
protein kinase C epsilon | 0.597 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2019 | ||||||||
|
deoxyribonuclease 2, lysosomal | 0.700 | 0.462 | 4.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2009 | ||||||||
|
fibroblast growth factor receptor substrate 3 | 0.890 | 0.115 | 0.55 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2009 | ||||||||
|
glutaryl-CoA dehydrogenase | 0.691 | 0.385 | 4.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2018 | ||||||||
|
coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2019 | |||||||||
|
synaptonemal complex central element protein 2 | 1.000 | 0.115 | 0.28 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2018 | ||||||||
|
H2A clustered histone 6 | 0.821 | 0.269 | 0.60 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2009 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2016 | ||||||||
|
solute carrier family 17 member 1 | 0.760 | 0.462 | 4.1E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2009 | 2009 | ||||||||
|
non-SMC condensin II complex subunit H2 | 0.805 | 0.385 | 2.9E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2009 | 2009 | ||||||||
|
tripartite motif containing 38 | 0.792 | 0.346 | 1.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2009 | 2009 | ||||||||
|
spectrin alpha, erythrocytic 1 | 0.638 | 0.538 | 2.6E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 7 | 2009 | 2019 | ||||||||
|
MYC associated factor X | 0.553 | 0.769 | 0.83 |
|
phenotype | 0.100 | None | 1.000 | 1 | 8 | 2009 | 2019 | ||||||||
|
CHURC1-FNTB readthrough | 5.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 8 | 2009 | 2019 | ||||||||||
|
farnesyltransferase, CAAX box, beta | 1.000 | 0.077 | 7.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 8 | 2009 | 2019 | ||||||||
|
microtubule associated serine/threonine kinase 1 | 0.711 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 9 | 2009 | 2018 |